Terumo Corp. (OTCMKTS:TRUMY) Sees Large Decline in Short Interest

Terumo Corp. (OTCMKTS:TRUMY) was the recipient of a significant decline in short interest during the month of May. As of May 15th, there was short interest totaling 14,067 shares, a decline of 54.4% from the April 30th total of 30,823 shares. Based on an average daily volume of 679,301 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the company’s stock are short sold.

Wall Street Analyst Weigh In

TRUMY has been the subject of several research analyst reports. Nomura upgraded Terumo to a “hold” rating in a report on Tuesday, February 24th. Zacks Research raised shares of Terumo to a “hold” rating in a report on Thursday, April 9th. Two analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold”.

Terumo Stock Performance

Shares of TRUMY traded down $0.10 on Friday, reaching $15.04. The company’s stock had a trading volume of 103,669 shares, compared to its average volume of 260,081. The stock’s 50 day simple moving average is $13.45 and its two-hundred day simple moving average is $13.90. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.51 and a quick ratio of 0.89. The stock has a market capitalization of $22.19 billion, a P/E ratio of 24.66 and a beta of 0.62. Terumo has a 12-month low of $12.08 and a 12-month high of $19.60.

Terumo (OTCMKTS:TRUMY) last announced its earnings results on Friday, May 15th. The company reported $0.11 EPS for the quarter, meeting analysts’ consensus estimates of $0.11. Terumo had a net margin of 12.09% and a return on equity of 9.35%. The business had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.84 billion. Research analysts forecast that Terumo will post 0.63 earnings per share for the current fiscal year.

About Terumo

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.